Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05501600 · ClinicalTrials.gov registry record · Phase 1
Neural Correlates of Lidocaine Analgesia
A Phase 1 study, sponsored by Keith M Vogt.
- Completed
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
NCT05501600 is a Phase 1 study that has completed, run by Keith M Vogt. The registered enrollment target is 30 participants.
The verdict
NCT05501600, a Phase 1 study, has completed, sponsored by Keith M Vogt.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to characterize the effects of intravenous lidocaine on pain processing and cognitive function. Functional magnetic resonance imaging will be used to identify the neural correlates of these phenomena. The study will consist of 1 visit and involves no long-term follow up.
Interventions
- DRUG Lidocaine IV
- DEVICE Peripheral Nerve Stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2022-11-22 |
| Est. Completion | 2023-11-17 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05501600
The ClinicalTrials.gov registry entry for NCT05501600 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Keith M Vogt, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Lidocaine IV is the first listed.
NCT05501600 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05501600 about?
NCT05501600 is a clinical study titled "Neural Correlates of Lidocaine Analgesia". The purpose of this study is to characterize the effects of intravenous lidocaine on pain processing and cognitive function. Functional magnetic resonance imaging will be used to identify the neural correlates of these phenomena. The study will consist of 1 visit and involves no long-term follow up.
What is the current status of trial NCT05501600?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2022-11-22. Estimated completion is 2023-11-17.
What interventions are being tested in trial NCT05501600?
The interventions under investigation include: Lidocaine IV (DRUG), Peripheral Nerve Stimulation (DEVICE).
Who is sponsoring clinical trial NCT05501600?
This trial is sponsored by Keith M Vogt, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.